ONCOLOGIE is an oncology therapeutics company committed to delivering better outcomes for cancer patients through an improved understanding of which patients will benefit from each drug in the pipeline. The current pipeline is focused on mid-stage clinical programs that modify the immune system to enhance efficacy of current standards of care and emerging immunotherapy agents. Headquartered in Boston, Massachusetts and Shanghai, China, Oncologie is working with global partners to acquire and develop innovative drugs for cancer patients around the world. WWW.ONCOLOGIE.INTERNATIONAL
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/07/18 | $16,500,000 | Seed |
China Merchant Bank Investments Nan Fung Volcanics Ventures | undisclosed |
| 06/10/19 | $80,000,000 | Series B |
Korea Investment Partners Nan Fung Panacea Ventures | undisclosed |
